Search
Anika Therapeutics Inc
ANIKAdd to Watchlist
21.240USD
+0.150+0.71%
Market hours 10/23, 09:56（ET）
284.19MMarket Cap
LossP/E TTM
Anika Therapeutics Inc (ANIK) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Anika Therapeutics Inc in the past month.
Strong Buy
1 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
23.000USD+15.12%
ANIK Analyst Recommendation Trends
In the current month, ANIK has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ANIK average Analyst price target in the last month is 23.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
ANIK Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Medtronic PLC
MDT
9
11
11
0
0
31
Dexcom Inc
DXCM
13
13
4
0
0
30
Abbott Laboratories
ABT
11
14
4
0
0
29
Stryker Corp
SYK
10
14
5
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
11
0
0
24
Repligen Corp
RGEN
5
13
3
0
0
21
Financial Forecasting
Based on analysts' estimates, ANIK EPS is projected to reach 0.060 in FY2026Q3, following reported EPS of 0.248 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.21
-0.16
-0.08
0.06
0.10
Actual
0.02
-0.37
0.25
--
--
Surprise
+109.52%
-133.54%
+410.30%
--
--
FAQs
What is Anika Therapeutics Inc's expected revenue for the next quarter?
Anika Therapeutics Inc's expected revenue is 29.44M.
What is Anika Therapeutics Inc's price target?
Analysts forecast that Anika Therapeutics Inc's price target is USD 23.00, with the highest forecast at USD 23.00 and the lowest forecast at USD 23.00.
How have Anika Therapeutics IncANIK's recent earnings per share performed?
The market expectation was USD 0.25, while Anika Therapeutics IncANIK's earnings per share (EPS) for the previous quarter was USD -0.37. EPS for the next quarter is expected at USD 0.06.
What is the analyst rating for Anika Therapeutics Inc?
Based on the ratings of Anika Therapeutics Inc's stock from 2 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.